25 results on '"De Nitto D"'
Search Results
2. P543 Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
3. P.02.5 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTENANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS
4. P362 Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
5. P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up
6. P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up
7. P024 Stratification of ulcerative colitis patients according to distinctive tissue cytokine profiles
8. P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS
9. P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE
10. P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS
11. P332 Adherence to anti-tumor necrosis factor alpha therapies in inflammatory bowel diseases: Experience from four referral Italian centers
12. OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER
13. P.1.101: LACTOBACILLI CASEI (LC) REDUCE TRYPSIN EXPRESSION IN INTESTINAL CELLS THEREBY LEADING TO INACTIVATION OF PAR2 AND UP-REGULATION OF ZO-1
14. OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES
15. P.1.40: IL-21 PRODUCTION IS POSITIVELY REGULATED BY IL-15 IN CELIAC DISEASE MUCOSA
16. P.1.33: 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE SENSITIZES COLON CANCER (CC) CELLS TO TRAIL THROUGH MODULATION OF DEATH RECEPTOR (DR)5 AND SURVIVIN
17. The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies
18. P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS
19. MESALAZINE'S ANTI-INFLAMMATORY ACTION THROUGH THE PPARγ IN CELIAC DISEASE
20. COLON MUCOSA CULTURE OF BIOPSIES FROM PATIENTS WITH UNTREATED COELIAC DISEASE, AN ALTERNATIVE DIAGNOSTIC SITE
21. OC3.09.1 THE ORAL MUCOSA PATCH TEST: A NEW TOOL TO IDENTIFY ALIMENTARY INTOLERANCE TO FOODS NICKEL CONTAINS
22. PA.38 ORGAN CULTURE SYSTEM AS A MACHINERY TO DETECT COELIAC DISEASE
23. PA.43 MESALAZINE EFFECT ON CELIAC DISEASE MUCOSA
24. OC3.05.1 CELIAC DISEASE DIAGNOSIS: HAS THE TIME COME TO CHANGE THE GOLD STANDARD?
25. PA.34 IMMUNO-CHROMATOGRAPHIC ASSAY (EU-TTG SCREEN) IN THE ORGAN CULTURE SYSTEM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.